Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 25.06 is in line with its 1-year average of 23.46, around the middle of its 1-year range (12.67–38.00).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 25.06.
CURRENT RATIO
25.06
CURRENT RATIO AVG TTM
N/A
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.67
median of 820 covered companies
CURRENT VS SECTOR MEDIAN
+581.82%
vs the sector median at left
SpyGlass Pharma, Inc. Common Stock
Market Cap
$842.52M
Current Ratio
25.06
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$835.55M
Current Ratio
4.92
TTM Avg
7.19
3Y Avg
6.36
5Y Avg
8.34
Market Cap
$830.54M
Current Ratio
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
Market Cap
$857.63M
Current Ratio
3.05
TTM Avg
43.83
3Y Avg
35.58
5Y Avg
35.58
Market Cap
$860.72M
Current Ratio
1.95
TTM Avg
2.27
3Y Avg
2.05
5Y Avg
2.13
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. Common Stock (SGP) | $842.52M | 25.06 | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $835.55M | 4.92 | 7.19 | 6.36 | 8.34 |
| Alumis Inc. (ALMS)vs › | $834.31M | 6.74 | 5.17 | 5.15 | 5.15 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $830.54M | 9.52 | 4.26 | 6.09 | 7.80 |
| Beta Bionics, Inc. (BBNX)vs › | $830.96M | 8.88 | 7.47 | 6.98 | 6.98 |
| QuidelOrtho Corporation (QDEL)vs › | $857.36M | 1.39 | 1.36 | 1.46 | 2.28 |
| SL Science Holding Ltd (SLBT)vs › | $857.63M | 3.05 | 43.83 | 35.58 | 35.58 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $860.72M | 1.95 | 2.27 | 2.05 | 2.13 |
| SI-BONE, Inc. (SIBN)vs › | $862.50M | 9.15 | 8.11 | 7.93 | 9.72 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $865.23M | 16.16 | 3.88 | 3.97 | 4.50 |
Current Ratio
25.06
Quick Ratio
25.06
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 25.06 |
| 2026-03-31 | 38.00 |
| 2025-12-31 | 12.67 |
| 2025-09-30 | 18.11 |
